Insights

Gathering insights about Enliven…

Similar companies to Enliven

Enliven Tech Stack

Enliven uses 8 technology products and services including RSS, reCAPTCHA, HTTP/3, and more. Explore Enliven's tech stack below.

RSS
Content Management System
reCAPTCHA
Security
HTTP/3
Web & Portal Technology
Google Search Console
Web Analytics
GoDaddy
Web Hosting
Nginx
Web Servers
Twitter
Widgets
Custom Twitter Feeds
Widgets

Media & News

Enliven Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares
BURLINGAME, Calif., June 15, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that it has closed its upsized underwritten public offering of 10,533,334 shares of its common stock, which includes the full exercise of the underwriters' option to purchase 1,600,000 additional shares of its common stock, at a price to the public of $37.50 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 1,733,333 shares of its common stock at a price to the public of $37.499 per pre-funded warrant, which represents the per share public offering price of each share of Enliven's common stock less the $0.001 per share exercise price for each pre-funded warrant.
Jun 15, 2026 | www.prnewswire.com
Enliven Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants
Enliven Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants PR Newswire
Jun 11, 2026 | www.gurufocus.com
Enliven Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants
BURLINGAME, Calif., June 11, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that it has priced its previously announced upsized underwritten public offering of 8,933,334 shares of its common stock at a price to the public of $37.50 per share and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase up to 1,733,333 shares of Enliven's common stock at a price to the public of $37.499 per pre-funded warrant, which represents the per share public offering price of each share of Enliven's common stock less the $0.001 per share exercise price for each pre-funded warrant.
Jun 11, 2026 | www.prnewswire.com
Enliven Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
BURLINGAME, Calif., June 11, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that it has commenced an underwritten public offering of $250.0 million of shares of its common stock and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase shares of Enliven's common stock.
Jun 11, 2026 | www.prnewswire.com
Enliven Therapeutics, Inc. (ELVN) Discusses Updated Phase 1 ENABLE Trial Data for ELVN-001 in Previously Treated Chronic Myeloid Leukemia Transcript
Enliven Therapeutics, Inc. (ELVN) Discusses Updated Phase 1 ENABLE Trial Data for ELVN-001 in Previously Treated Chronic Myeloid Leukemia Transcript
Jun 11, 2026 | seekingalpha.com
Enliven Therapeutics Announces Updated Positive Phase 1 Clinical Data and Alignment with FDA on Key Phase 3 Trial Design Components
61% overall MMR and 48% MMR achievement by 24 weeks in the 80 mg QD Phase 1b cohort 67% overall MMR and 55% MMR achievement by 24 weeks in all Phase 1b patients who had previously received 1 or 2 prior unique TKIs Favorable safety and tolerability profile with 161 patients enrolled and a median treatment duration of 35 weeks Alignment with the FDA on 80 mg QD as the recommended Phase 3 dose and on the 2L+ patient population for the ENABLE-2 pivotal trial, which is expected to initiate in the second half of this year BURLINGAME, Calif., June 11, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today presented updated positive data from the Phase 1 ENABLE clinical trial evaluating ELVN-001 in patients with previously treated chronic myeloid leukemia (CML).
Jun 11, 2026 | www.prnewswire.com
Enliven Therapeutics to Host Webcast Conference Call to Discuss Phase 1 ELVN-001 Clinical Data Being Presented at EHA 2026 Congress
Enliven will host a webcast conference call on June 11, at 8:30 a.m. ET BURLINGAME, Calif.
Jun 03, 2026 | www.prnewswire.com

Enliven's Email Address Formats

Enliven uses at least 1 format(s):

Enliven Email Formats	Example	Percentage
FLast@enlivenhq.com	JDoe@enlivenhq.com	57%
First@enlivenhq.com	John@enlivenhq.com	29%
FirLast@enlivenhq.com	JohDoe@enlivenhq.com	14%

Frequently Asked Questions

Where is Enliven's headquarters located?

Enliven's main headquarters is located at St. Louis, Missouri 63104 United States. The company has employees across 5 continents, including North AmericaOceaniaAsia.

What is Enliven's phone number?

You can contact Enliven's main corporate office by phone at

+1-314-632-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Enliven's stock symbol?

Enliven is a publicly traded company; the company's stock symbol is ELVN.

What is Enliven's official website and social media links?

Enliven's official website is enlivenhq.com and has social profiles on LinkedIn.

What is Enliven's NAICS code?

Enliven's NAICS code is 5112 - Software Publishers.

How many employees does Enliven have currently?

As of May 2026, Enliven has approximately 26 employees across 5 continents, including North AmericaOceaniaAsia. Key team members include Founder & President: I. R.Nutrition Club Owner: B. H.Director Of Technology: T. L.. Explore Enliven's employee directory with LeadIQ.

What industry does Enliven belong to?

Enliven operates in the Software Development industry.

What technology does Enliven use?

Enliven's tech stack includes RSSreCAPTCHAHTTP/3Google Search ConsoleGoDaddyNginxTwitterCustom Twitter Feeds.

What is Enliven's email format?

Enliven's email format typically follows the pattern of FLast@enlivenhq.com. Find more Enliven email formats with LeadIQ.

When was Enliven founded?

Enliven was founded in 2012.

Enliven

Q: What is Enliven's official website and social media links?

Enliven's official website is enlivenhq.com. Enliven has social profiles on LinkedIn.

Q: How many employees does Enliven have currently?

Enliven has approximately 26 employees.

Q: What technology does Enliven use?

Enliven's tech stack includes Open Graph, WP Engine, Metronet Profile Picture, jQuery Migrate, Google Cloud.

Q: What is Enliven's NAICS code?

Enliven's NAICS code is 5112 (Software Publishers).

Software DevelopmentMissouri, United States11-50 Employees

Enliven is a software consultancy helping expert professional services firms create healthy and sustainable digital work environments. We design and build highly functional, collaborative web apps for expert operations and project management processes.

When it just doesn't make sense to keep using that struggling legacy system, or you know you shouldn't be licensing your operational worldview from a SaaS provider, call us. Your employees deserve better tools and better days at work.

Company Overview

Headquarters: St. Louis, Missouri 63104 United States
Phone number: +1-314-632-****
Website: enlivenhq.com
Stock Symbol: ELVN
NAICS Code: 5112 - Software Publishers
Founded: 2012
Employees: 11-50

Media & News

Funding & Financials

$1M$10M
Enliven's revenue is estimated to be in the range of $1M$10M

Funding & Financials

$1M$10M
Enliven's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Enliven

Refresh

Energize (Acquired by Happy Horizon)

RESTORE

Vitality

ReNew

Revive

Energise | B Corp™

Sublime

Enliven Tech Stack

Media & News

Enliven Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Enliven Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants

Enliven Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants

Enliven Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Enliven Therapeutics, Inc. (ELVN) Discusses Updated Phase 1 ENABLE Trial Data for ELVN-001 in Previously Treated Chronic Myeloid Leukemia Transcript

Enliven Therapeutics Announces Updated Positive Phase 1 Clinical Data and Alignment with FDA on Key Phase 3 Trial Design Components

Enliven Therapeutics to Host Webcast Conference Call to Discuss Phase 1 ELVN-001 Clinical Data Being Presented at EHA 2026 Congress

Enliven's Email Address Formats

Frequently Asked Questions

Where is Enliven's headquarters located?

What is Enliven's phone number?

What is Enliven's stock symbol?

What is Enliven's official website and social media links?

What is Enliven's NAICS code?

How many employees does Enliven have currently?

What industry does Enliven belong to?

What technology does Enliven use?

What is Enliven's email format?

When was Enliven founded?

Enliven

Company Overview

Media & News

Enliven Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Enliven Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants

Enliven Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?